Trial Profile
Phase1 Clinical Trial of OTS102 in Subjects with Solid Tumors
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 12 May 2016
Price :
$35
*
At a glance
- Drugs Elpamotide (Primary)
- Indications Solid tumours
- Focus Adverse reactions
- 10 Jul 2012 New trial record